BioNTech SE (BNTX) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 9, 2026.
- Filings shown
- 19
- Open-market buys
- 0
- Open-market sells
- 26
Counts cover the 19 most recent Form 4 filings Tradune holds for BNTX (filed May 13 – Oct 9, 2026); the score below covers only the trailing 90 days (0 buys, 26 sells). SEC EDGAR Form 4 filings for BNTX last checked Nov 21, 2026, 09:00 UTC; the latest BNTX filing Tradune holds was filed Oct 9, 2026. This is not guaranteed to be the complete record — see BNTX's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 14 filings Tradune holds for BNTX filed Sep 8 – Oct 9, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
26 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 26 sales· 858,209 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Ugur SahinChief Executive Officer | 0 | 26 | — | 858,209 | −$84,232,245 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at BNTX
No open-market insider purchases (Form 4 code P) were reported for BNTX between May 13, 2026 and Oct 9, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 36,209 | $95.37 | 0 | −100% | Oct 9, 2026 |
| Open-market sale 10b5-1 box checked | 27,000 | $92.31 | 36,209 | −43% | Oct 8, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 24,000 | $95.86 | 63,209 | −28% | Oct 7, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 21,000 | $96.81 | 87,209 | −19% | Oct 6, 2026 |
| Open-market sale 10b5-1 box checked | 72,000 | $97.23 | 108,209 | −40% | Oct 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 17,000 | $96.72 | 180,209 | −8.6% | Oct 2, 2026 |
| Open-market sale 10b5-1 box checked | 17,000 | $97.46 | 197,209 | −7.9% | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 32,000 | $98.12 | 214,209 | −13% | Sep 30, 2026 |
| Open-market sale 10b5-1 box checked | 34,000 | $98.26 | 246,209 | −12% | Sep 29, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 34,000 | $98.47 | 280,209 | −11% | Sep 28, 2026 |
| Open-market sale 10b5-1 box checked | 27,000 | $98.69 | 314,209 | −7.9% | Sep 25, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 39,000 | $98.99 | 341,209 | −10% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 30,000 | $99.40 | 380,209 | −7.3% | Sep 23, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 46,000 | $100.72 | 410,209 | −10% | Sep 22, 2026 |
| Open-market sale 10b5-1 box checked | 33,000 | $97.81 | 456,209 | −6.7% | Sep 21, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 30,000 | $96.22 | 489,209 | −5.8% | Sep 18, 2026 |
| Open-market sale 10b5-1 box checked | 34,000 | $98.60 | 519,209 | −6.1% | Sep 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 15,000 | $96.09 | 553,209 | −2.6% | Sep 16, 2026 |
| Open-market sale 10b5-1 box checked | 34,000 | $96.49 | 568,209 | −5.6% | Sep 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 41,000 | $99.45 | 602,209 | −6.4% | Sep 14, 2026 |
| Open-market sale 10b5-1 box checked | 45,000 | $96.93 | 643,209 | −6.5% | Sep 11, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 20,500 | $96.31 | 688,209 | −2.9% | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 36,000 | $97.78 | 708,709 | −4.8% | Sep 9, 2026 |
| Open-market sale 10b5-1 box checked | 37,000 | $99.20 | 744,709 | −4.7% | Sep 8, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 31,500 | $103.52 | 781,709 | −3.9% | Sep 4, 2026 |
| Open-market sale 10b5-1 box checked | 45,000 | $102.85 | 813,209 | −5.2% | Sep 3, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Performance Share Unit | 15,103 | — | — | — | May 12, 2026 |
| Grant / award Option (right to buy) | 18,879 | — | — | — | May 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Performance Share Unit | 8,391 | — | — | — | May 12, 2026 |
| Grant / award Option (right to buy) | 10,488 | — | — | — | May 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Performance Share Unit | 10,069 | — | — | — | May 12, 2026 |
| Grant / award Option (right to buy) | 12,586 | — | — | — | May 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Option (right to buy) | 12,586 | — | — | — | May 12, 2026 |
| Grant / award Performance Share Unit | 10,069 | — | — | — | May 12, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Option (right to buy) | 12,586 | — | — | — | May 12, 2026 |
| Grant / award Performance Share Unit | 10,069 | — | — | — | May 12, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to BNTX's (Oct 9, 2026).
Frequently asked about BNTX insider activity
How many insiders bought BNTX stock in these Form 4 filings?
No open-market purchases (Form 4 code P) of BNTX shares were reported by BioNTech SE insiders between May 13, 2026 and Oct 9, 2026. The 19 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.
Who filed the most recent Form 4 for BNTX?
The most recent Form 4 on this page was filed by Ugur Sahin (Chief Executive Officer) on Oct 9, 2026, reporting 2 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market BNTX insider sale shown?
The largest open-market sale among the filings shown was 72,000 BNTX shares at $97.23 (about $7,000,646) by Ugur Sahin (Chief Executive Officer) on Oct 5, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for BNTX — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.